Key facts
- This page summarizes Troy A. Ignelzi's Form 4 filing for Harmony Biosciences Holdings, Inc. (HRMY).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 06 Apr 2026, 16:14.
Troy A. Ignelzi - 02 Apr 2026 Form 4 Insider Report for Harmony Biosciences Holdings, Inc. (HRMY)
- Reporting relationship
- Director
- Issuer ticker
- HRMY
- Reported as of
- 02 Apr 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 06 Apr 2026, 16:14:04 UTC
- Prior SEC filing
- 04 Feb 2026
- Next SEC filing
- 26 Jun 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Christian Ulrich, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Troy A. Ignelzi filed Form 4 for Harmony Biosciences Holdings, Inc. (HRMY) on 06 Apr 2026.
Change
- Previous filing in this sequence was filed on 04 Feb 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001579829
Primary reporting owner
Ignelzi Troy A.
- Relationship
- Director
- Address
- C/O HARMONY BIOSCIENCES HOLDINGS, INC., 630 W. GERMANTOWN PIKE, SUITE 215, PLYMOUTH MEETING
- Signature
- /s/ Christian Ulrich, Attorney-in-Fact
- Signature date
- 06 Apr 2026
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
HRMY
transaction
Derivative
Stock Option
Award
- Transaction value
- Shares
- +17,710
- Change %
- Price
- $0.000000*
- Shares after
- 17,710
- Date
- 02 Apr 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 17,710
- Exercise price
- $27.74
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The stock option shall vest in 36 equal monthly installments beginning on May 2, 2026.